Citogens

Citogens

CITOGENS

As a result of years of research by the St. Petersburg Institute of Bioregulation and Gerontology a new approach to the research of the physiologically active peptides was elaborated. This is based on the analysis of the amino acid sequence of polypeptides extracted from animal organs and tissues. Short peptide sequences were created that contain two-four amino acids. These sequences are the replicas of the”active participants” extracted from animals that construct a bigger group of polypeptides. This made possible to create a new type of products, which is called parapharmaceuticals that are called citogens.

As the citogens – contrary to the extract (group of polypeptides) – contain only one molecule type (the most important short polypeptides), their use is suggested at the initial phase of the peptide treatments when preventing the premature aging process and for short term treatments (3-4 times a year for 10 days) Detailes

  • VEZUGEN – Bioregulator for the normalization of the vessels function.
  • KRISTAGEN - Bioregulator for the normalization of the immune system.
  • KARTALAX - Bioregulator for the normalization of the cartilage and locomotors tissues.
  • OVAGEN - Bioregulator for the normalization of the liver, stomach function and for the gastrointestinal tract.
  • HONLUTEN - Bioregulator for the normalization of the mucous membrane of the lungs and bronchia.
  • PINEALON - Bioregulator for the normalization of the appropriate function of the brain cells.

View:
4 items